Alterations in DNA Methylation in Peripheral Blood May Indicate Lymphoma Development in Primary Sjögren's Disease
-
By
-
Hanna Lidberg
-
Cecilia Fugmann
-
Juliana Imgenberg-Kreuz
-
July 9, 2026
Clinical Scorecard: Alterations in DNA Methylation in Peripheral Blood May Indicate Lymphoma Development in Primary Sjögren's Disease
At a Glance
| Category | Detail |
|---|
| Condition | Primary Sjögren's Disease |
| Key Mechanisms | DNA methylation changes associated with lymphoma development |
| Target Population | Patients with Primary Sjögren's Disease |
| Care Setting | Rheumatology and autoimmune disease management |
Key Highlights
- DNA methylation patterns in blood may indicate lymphoma risk in SjD.
- Significant differential methylation observed in 473 CpG positions.
- 87% of identified DMPs were hypomethylated in patients pre-lymphoma.
- Functional enrichment linked to immune activation and leukocyte signaling.
- Altered immune cell proportions noted in patients sampled pre-lymphoma.
Guideline-Based Recommendations
Diagnosis
- Monitor DNA methylation patterns in patients with Primary Sjögren's Disease.
Management
- Integrate epigenetic markers with clinical assessments for risk stratification.
Monitoring & Follow-up
- Regularly assess immune cell proportions and methylation changes.
Risks
- Increased risk of lymphoma in patients with altered DNA methylation.
Patient & Prescribing Data
Patients diagnosed with Primary Sjögren's Disease.
Focus on early identification of high-risk patients through biomarker analysis.
Clinical Best Practices
- Utilize epigenetic profiling for early detection of lymphoma risk.
- Incorporate immune cell analysis in routine evaluations of SjD patients.
Related Resources & Content
